MedTrace Logo

Ethnic and Gender Based Admittance Patterns in the ICU

NCT05513456 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-08-27

No results posted yet for this study

Summary

The dominating proportion of patients in the ICU are men. Studies indicate that men receive more mechanical ventilation, vasoactive drugs, renal replacement therapy, invasive monitoring and have longer length of stay in the ICU. These differences do not unambiguously translate into a survival benefit for men; if survival would be altered if women were admitted to ICU in the same extent is unknown.

Factors affecting ICU admission include age, co-morbidities, physiological parameters (indicating severity of the acute illness) and, additionally, the number of available ICU beds. Factors that should not affect ICU admission include patient gender or ethnicity.

This study aims at studying if bias against women and people of certain ethnicities exist. Do clinicians have differing thresholds for ICU admission due to non-medical reasons?

The investigators propose testing this hypothesis using a blinded randomized factorial survey study.

Conditions

  • Critical Illness
  • Gender Equality
  • Discrimination, Sex
  • Discrimination, Racial

Interventions

BEHAVIORAL

Randomization to a different factors in the case descriptions

The case descriptions will include factors like age, co-morbid status and acute physiological parameters; but the factor of sex/gender will be randomized. Moreover, randomization to case description of typical vs non-typical national name will be done.

Sponsors & Collaborators

Principal Investigators

  • Max Bell, MD, PhD · Department of Physiology and Pharmacology, Karolinska Institutet

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-31
Primary Completion
2026-05-31
Completion
2026-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05513456 on ClinicalTrials.gov